On March 16, 2023, Michael C. Dugan, M.D., the Senior Vice President, Chief Medical Officer and Medical Director of Biocept (NASDAQ:BIOC), was terminated, effective March 17, 2023.
Effective March 17, 2023, the Company has promoted its Associate Medical Director, Nathaniel Sweed, M.D., to Medical Director. The Company has also designated a new laboratory medical director of the Company’s CLIA-certified, CAP-accredited clinical laboratory in San Diego, California.